Ambitious Push to Resume Routine Immunisations to Save 50 Million Lives – COVAX Waits for Indian Vaccines 26/04/2021 Kerry Cullinan Fifty countries have not yet resumed routine immunisations disrupted by the COVID-19 pandemic, affecting 228 million people – mainly children – and there have already been serious measles outbreaks in Yemen, Pakistan and the Democratic Republic of the Congo, according to World Health Organization (WHO) director general Dr Tedros Adhanom Ghebreyusus. To address this, the […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EMA Reviews Link Between Blood Clots and Johnson & Johnson Vaccine 09/04/2021 Kerry Cullinan The European Medicines Agency is reviewing the cases of four people who developed blood clots after receiving Johnson & Johnson’s (J&J) COVID-19 vaccine, the regulator announced on Friday. “Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with COVID-19 Vaccine Janssen. One case occurred in a clinical trial and […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> Posts navigation Older postsNewer posts